These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32805954)

  • 1. Small Morph Nanoparticles for Deep Tumor Penetration via Caveolae-Mediated Transcytosis.
    Zhang Z; Wang T; Yang R; Fu S; Guan L; Hou T; Mu W; Pang X; Liang S; Liu Y; Zhang N
    ACS Appl Mater Interfaces; 2020 Aug; 12(34):38499-38511. PubMed ID: 32805954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-drug delivery system with enhanced tumour penetration and layered anti-tumour efficacy.
    Zhang N; Feng N; Xin X; Zhang J; Wu D; Jiang Q; Yu T; Gao M; Zhao S; Yang H; Tian Q
    Nanomedicine; 2022 Sep; 45():102592. PubMed ID: 35905842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
    Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
    Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcytosis-Inducing Multifunctional Albumin Nanomedicines with Deep Penetration Ability for Image-Guided Solid Tumor Treatment.
    Lee H; Park B; Lee J; Kang Y; Han M; Lee J; Kim C; Kim WJ
    Small; 2023 Dec; 19(50):e2303668. PubMed ID: 37612796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
    Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
    Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Microenvironment Stimuli-Responsive Nanoparticles for Programmed Anticancer Drug Delivery.
    Jia N; Li W; Liu D; Wu S; Song B; Ma J; Chen D; Hu H
    Mol Pharm; 2020 May; 17(5):1516-1526. PubMed ID: 32243181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZIF-based carbon dots with lysosome-Golgi transport property as visualization platform for deep tumour therapy
    Zhang X; Jiang J; Yu Q; Zhou P; Yang S; Xia J; Deng T; Yu C
    Nanoscale; 2022 Jun; 14(23):8510-8524. PubMed ID: 35660835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile fabrication of multi-pocket nanoparticles with stepwise size transition for promoting deep penetration and tumor targeting.
    Hou X; Zhong D; Li Y; Mao H; Yang J; Zhang H; Luo K; Gong Q; Gu Z
    J Nanobiotechnology; 2021 Apr; 19(1):111. PubMed ID: 33874945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
    Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
    Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxymethyl Chitosan-Modified Polyamidoamine Dendrimer Enables Progressive Drug Targeting of Tumors via pH-Sensitive Charge Inversion.
    Qi X; Qin J; Fan Y; Qin X; Jiang Y; Wu Z
    J Biomed Nanotechnol; 2016 Apr; 12(4):667-78. PubMed ID: 27301193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.
    Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S
    Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive bromelain nanoparticles by ortho ester crosslinkage for enhanced doxorubicin penetration in solid tumor.
    Wang X; Xu J; Xu X; Fang Q; Tang R
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():111004. PubMed ID: 32487411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.
    Cun X; Chen J; Ruan S; Zhang L; Wan J; He Q; Gao H
    ACS Appl Mater Interfaces; 2015 Dec; 7(49):27458-66. PubMed ID: 26633260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
    Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
    Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sequentially responsive and structure-transformable nanoparticle with a comprehensively improved 'CAPIR cascade' for enhanced antitumor effect.
    Xu C; Sun Y; Yu Y; Hu M; Yang C; Zhang Z
    Nanoscale; 2019 Jan; 11(3):1177-1194. PubMed ID: 30601512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro/vivo antitumor study of modified-chitosan/carboxymethyl chitosan "boosted" charge-reversal nanoformulation.
    Li L; Zhang P; Li C; Guo Y; Sun K
    Carbohydr Polym; 2021 Oct; 269():118268. PubMed ID: 34294300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic Tumors.
    Wang G; Zhou Z; Zhao Z; Li Q; Wu Y; Yan S; Shen Y; Huang P
    ACS Nano; 2020 Apr; 14(4):4890-4904. PubMed ID: 32286784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcytosis of Nanomedicine for Tumor Penetration.
    Liu Y; Huo Y; Yao L; Xu Y; Meng F; Li H; Sun K; Zhou G; Kohane DS; Tao K
    Nano Lett; 2019 Nov; 19(11):8010-8020. PubMed ID: 31639306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.